| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |